Skip to main content

Find Clinical Trials

Home
Conditions
FLT3 Internal Tandem Duplication Positive

Clinical trial condition

FLT3 Internal Tandem Duplication Positive

Explore clinical trials studying FLT3 Internal Tandem Duplication Positive. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

FLT3 Internal Tandem Duplication Positive trial results

Recruiting

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

NCT07259707

Conditions: Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication Positive, Fit Patients, +8 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT01892371

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +20 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details